Deciphering the peptidome of urine from ovarian cancer patients and healthy controls

BACKGROUND: Ovarian cancer (OvCa) is the most lethal gynecological malignancy. The emergence of high-throughput technologies, such as mass spectrometry, has allowed for a paradigm shift in the way we search for novel biomarkers. Urine-based peptidomic profiling is a novel approach that may result in...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Christopher R, Batruch, Ihor, Bauça, Josep Miquel, Kosanam, Hari, Ridley, Julia, Bernardini, Marcus Q, Leung, Felix, Diamandis, Eleftherios P, Kulasingam, Vathany
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065538/
https://www.ncbi.nlm.nih.gov/pubmed/24982608
http://dx.doi.org/10.1186/1559-0275-11-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065538/
https://www.ncbi.nlm.nih.gov/pubmed/24982608
http://dx.doi.org/10.1186/1559-0275-11-23

Ejemplares similares